174 related articles for article (PubMed ID: 17268522)
1. Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study.
Farinasso L; Bertorello N; Garbarini L; Gajno TM; Barisone E; Artesani L; Valori A; Giacchino M; Pastore G; Saracco P
Leukemia; 2007 Mar; 21(3):552-6. PubMed ID: 17268522
[No Abstract] [Full Text] [Related]
2. Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: an AIEOP experience.
Santoro N; Colombini A; Silvestri D; Grassi M; Giordano P; Parasole R; Barisone E; Caruso R; Conter V; Valsecchi MG; Masera G; Rizzari C
J Pediatr Hematol Oncol; 2013 Jul; 35(5):348-55. PubMed ID: 23619106
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters.
Wermes C; von Depka Prondzinski M; Lichtinghagen R; Barthels M; Welte K; Sykora KW
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S143-6. PubMed ID: 10650855
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
[TBL] [Abstract][Full Text] [Related]
5. Formation of a calcified "cast" in a long-term indwelling central venous catheter: a case report.
Hughes DB; Ullery BW; Spigland N
J Pediatr Surg; 2006 Nov; 41(11):1927-9. PubMed ID: 17101373
[TBL] [Abstract][Full Text] [Related]
6. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
[TBL] [Abstract][Full Text] [Related]
7. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement.
McLean TW; Fisher CJ; Snively BM; Chauvenet AR
J Clin Oncol; 2005 May; 23(13):3024-9. PubMed ID: 15860859
[TBL] [Abstract][Full Text] [Related]
8. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study.
Abbas AA; Fryer CJ; Paltiel C; Chedid F; Felimban SK; Yousef AA; Khattab TM
Pediatr Blood Cancer; 2004 Apr; 42(4):325-31. PubMed ID: 14966828
[TBL] [Abstract][Full Text] [Related]
10. Dermatan sulphate for heparin-induced thrombocytopenia and central venous catheter-related deep vein thrombosis in a child with acute lymphoblastic leukemia.
Verso M; Mazzarino I; Agnelli G; Stefanelli M; Ceppi S; Paoletti F
Haematologica; 2004 Apr; 89(4):ECR06. PubMed ID: 15075098
[No Abstract] [Full Text] [Related]
11. Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia: results from a meta-analysis.
Caruso V; Iacoviello L; Di Castelnuovo A; Storti S; Donati MB
J Thromb Haemost; 2007 Mar; 5(3):621-3. PubMed ID: 17229043
[No Abstract] [Full Text] [Related]
12. Central venous line-related thrombosis in children: association with central venous line location and insertion technique.
Male C; Chait P; Andrew M; Hanna K; Julian J; Mitchell L;
Blood; 2003 Jun; 101(11):4273-8. PubMed ID: 12560228
[TBL] [Abstract][Full Text] [Related]
13. Low rate of severe venous thromboses in children with ALL treatment according to COALL-92 and -97 protocol.
Mauz-Körholz C; Nürnberger W; Irsfeld H; Körholz D; Göbel U
Klin Padiatr; 1999; 211(4):215-7. PubMed ID: 10472553
[TBL] [Abstract][Full Text] [Related]
14. Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia.
Handrup MM; Møller JK; Frydenberg M; Schrøder H
Pediatr Blood Cancer; 2010 Aug; 55(2):309-13. PubMed ID: 20582964
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis and acute lymphoblastic leukaemia.
Payne JH; Vora AJ
Br J Haematol; 2007 Aug; 138(4):430-45. PubMed ID: 17608766
[TBL] [Abstract][Full Text] [Related]
16. Clinical Course of Cerebral Venous Thrombosis in Adult Acute Lymphoblastic Leukemia.
Zuurbier SM; Lauw MN; Coutinho JM; Majoie CB; van der Holt B; Cornelissen JJ; Middeldorp S; Biemond BJ; Stam J
J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1679-84. PubMed ID: 25934140
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of venous thrombosis in children with cancer.
Piovesan D; Attard C; Monagle P; Ignjatovic V
Thromb Haemost; 2014 Jun; 111(6):1015-21. PubMed ID: 24522152
[TBL] [Abstract][Full Text] [Related]
18. Catheter-directed thrombolysis in a child with acute lymphoblastic leukemia and extensive deep vein thrombosis.
Savage SA; Young G; Reaman GH
Med Pediatr Oncol; 2000 Mar; 34(3):215-7. PubMed ID: 10696131
[No Abstract] [Full Text] [Related]
19. Profile of thrombin generation in children with acute lymphoblastic leukemia treated by Berlin-Frankfurt-Münster (BFM) protocols.
Lejhancova-Tousovska K; Zapletal O; Vytiskova S; Strbackova P; Sterba J
Blood Coagul Fibrinolysis; 2012 Mar; 23(2):144-54. PubMed ID: 22227959
[TBL] [Abstract][Full Text] [Related]
20. [Intensification of chemotherapy in maintenance therapy and in periodic reinduction of remission in high-risk childhood ALL].
Indiano JM; Echaniz I; Humayor J; Delgado A
An Esp Pediatr; 1988 Oct; 29 Suppl 34():94-8. PubMed ID: 3214047
[No Abstract] [Full Text] [Related]
[Next] [New Search]